BOTOX® vs. XEOMIN® for Chronic Migraine

NCT05598723 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

128

Enrollment

FED

Sponsor class

Conditions

Chronic Migraine

Interventions

DRUG: IncobotulinumtoxinA (XEOMIN®)
DRUG: OnabotulinumtoxinA (BOTOX®)

Sponsor

Naval Medical Center Camp Lejeune